Nektar Therapeutics
NKTR
NKTR
137 hedge funds and large institutions have $183M invested in Nektar Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 34
0.19% more ownership
Funds ownership: 4.91% → 5.1% (+0.19%)
Holders
137
Holding in Top 10
–
Calls
$182K
Puts
$23K
Top Buyers
| 1 | +$2.43M | |
| 2 | +$1.77M | |
| 3 | +$1.44M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.24M |
| 5 |
BlackRock
New York
|
+$1.06M |
Top Sellers
| 1 | -$2.54M | |
| 2 | -$944K | |
| 3 | -$933K | |
| 4 |
Two Sigma Investments
New York
|
-$580K |
| 5 |
Two Sigma Advisers
New York
|
-$436K |